New shot shows promise against fatty liver disease
NCT ID NCT05989711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a weekly injection called pemvidutide in 212 adults with NASH, a serious liver condition linked to fat buildup. The goal was to see if the drug could reduce liver fat and scarring without worsening the disease. Participants received either the drug or a placebo for 24 weeks, and researchers measured changes in liver health through biopsies and scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pemvidutide (a weekly injection)
What this could lead to
If successful, this could provide a new treatment to reduce liver fat and scarring in people with NASH, potentially preventing progression to cirrhosis.
What could go wrong
This is an early Phase 2 trial with only 212 participants. The drug may not work better than placebo, and side effects are possible. Results need confirmation in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altimmune Clinial Study Site
Tucson, Arizona, 85704, United States
-
Altimmune Clinical Study Site
Chandler, Arizona, 85224, United States
-
Altimmune Clinical Study Site
Peoria, Arizona, 85345, United States
-
Altimmune Clinical Study Site
Tucson, Arizona, 85701, United States
-
Altimmune Clinical Study Site
North Hollywood, California, 33019, United States
-
Altimmune Clinical Study Site
Panorama City, California, 91402, United States
-
Altimmune Clinical Study Site
Englewood, Colorado, 80110, United States
-
Altimmune Clinical Study Site
Bradenton, Florida, 34201, United States
-
Altimmune Clinical Study Site
Fort Myers, Florida, 33912, United States
-
Altimmune Clinical Study Site
Hialeah Gardens, Florida, 33018, United States
-
Altimmune Clinical Study Site
Miami Lakes, Florida, 33014, United States
-
Altimmune Clinical Study Site
Port Orange, Florida, 32123, United States
-
Altimmune Clinical Study Site
Sarasota, Florida, 34240, United States
-
Altimmune Clinical Study Site
West Palm Beach, Florida, 33401, United States
-
Altimmune Clinical Study Site
Dalton, Georgia, 30720, United States
-
Altimmune Clinical Study Site
Marietta, Georgia, 30006, United States
-
Altimmune Clinical Study Site
Bastrop, Louisiana, 78602, United States
-
Altimmune Clinical Study Site
Shreveport, Louisiana, 71101, United States
-
Altimmune Clinical Study Site
Clarksville, Tennessee, 37040, United States
-
Altimmune Clinical Study Site
Germantown, Tennessee, 38138, United States
-
Altimmune Clinical Study Site
Austin, Texas, 73301, United States
-
Altimmune Clinical Study Site
Bellaire, Texas, 77401, United States
-
Altimmune Clinical Study Site
Edinburg, Texas, 78539, United States
-
Altimmune Clinical Study Site
Edinburg, Texas, 78540, United States
-
Altimmune Clinical Study Site
Georgetown, Texas, 78626, United States
-
Altimmune Clinical Study Site
Houston, Texas, 77036, United States
-
Altimmune Clinical Study Site
San Antonio, Texas, 78201, United States
-
Altimmune Clinical Study Site
San Antonio, Texas, 78204, United States
-
Altimmune Clinical Study Site
West Jordan, Utah, 84081, United States
-
Altimmune Clinical Study Site
San Juan, 00901, Puerto Rico
-
Austin Health
Heidelberg, Victoria, 3084, Australia
-
Box Hill Hospital
Box Hill, Victory, 3128, Australia
-
Fiona Stanley Hospital
Murdoch, Western Australia, 6150, Australia
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
-
Liverpool Hospital
Liverpool, New South Wales, 2170, Australia
-
Monash Hospital
Clayton, Victory, 3168, Australia
-
Princess Alexandra Hospital/ Translational Research Institute
Woolloongabba, Queensland, 4102, Australia
-
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
-
Sir Charles Gairdner Hospital
Nedlands, Western Australia, 6009, Australia
-
St. Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia